• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾小球上皮损伤在TRIDENT队列中糖尿病肾病患者肾功能下降中的作用

The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort.

作者信息

Palmer Matthew B, Abedini Amin, Jackson Casey, Blady Shira, Chatterjee Shatakshee, Sullivan Katie Marie, Townsend Raymond R, Brodbeck Jens, Almaani Salem, Srivastava Anand, Avasare Rupali, Ross Michael J, Mottl Amy K, Argyropoulos Christos, Hogan Jonathan, Susztak Katalin

机构信息

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

出版信息

Kidney Int Rep. 2021 Feb 3;6(4):1066-1080. doi: 10.1016/j.ekir.2021.01.025. eCollection 2021 Apr.

DOI:10.1016/j.ekir.2021.01.025
PMID:33912757
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8071659/
Abstract

INTRODUCTION

Although diabetic kidney disease (DKD) is responsible for more than half of all chronic and end-stage kidney disease (ESKD), the association of light (LM) and electron microscopic (EM) structural changes with clinical parameters and prognosis in DKD is incompletely understood.

METHODS

This is an interim analysis of 62 patients diagnosed with biopsy-confirmed DKD from the multicenter TRIDENT (Transformative Research in Diabetic Nephropathy) study. Twelve LM and 8 EM descriptors, representing changes in glomeruli, tubulointerstitium, and vasculature were analyzed for their relationship with clinical measures of renal function. Patients were followed every 6 months.

RESULTS

Multivariable linear regression analysis revealed that estimated glomerular filtration rate (eGFR) upon enrollment correlated the best with interstitial fibrosis. On the other hand, the rate of kidney function decline (eGFR slope) correlated the most with glomerular lesions including global glomerulosclerosis and mesangiolysis. Unbiased clustering analysis based on histopathologic data identified 3 subgroups. The first cluster, encompassing subjects with the mildest histologic lesions, had the most preserved kidney function. The second and third clusters had similar degrees of kidney dysfunction and structural damage, but differed in the degree of glomerular epithelial cell and podocyte injury (podocytopathy DKD subtype). Cox proportional hazard analysis showed that subjects in cluster 2 had the highest risk to reach ESKD (hazard ratio: 17.89; 95% confidence interval: 2.13-149.79). Glomerular epithelial hyperplasia and interstitial fibrosis were significant predictors of ESKD in the multivariate model.

CONCLUSION

The study highlights the association between fibrosis and kidney function and identifies the role of glomerular epithelial changes and kidney function decline.

摘要

引言

尽管糖尿病肾病(DKD)是所有慢性和终末期肾病(ESKD)的半数以上病因,但对于DKD中光镜(LM)和电镜(EM)结构变化与临床参数及预后之间的关联,我们尚未完全了解。

方法

这是一项对来自多中心TRIDENT(糖尿病肾病转化研究)研究中62例经活检确诊为DKD患者的中期分析。分析了代表肾小球、肾小管间质和血管系统变化的12个光镜和8个电镜指标与肾功能临床指标之间的关系。患者每6个月随访一次。

结果

多变量线性回归分析显示,入组时的估计肾小球滤过率(eGFR)与间质纤维化的相关性最佳。另一方面,肾功能下降率(eGFR斜率)与包括全球肾小球硬化和血管系膜溶解在内的肾小球病变相关性最大。基于组织病理学数据的无偏聚类分析确定了3个亚组。第一组包括组织学病变最轻的受试者,其肾功能保存最完好。第二组和第三组有相似程度的肾功能障碍和结构损伤,但在肾小球上皮细胞和足细胞损伤程度(足细胞病DKD亚型)方面有所不同。Cox比例风险分析显示,第2组受试者达到ESKD的风险最高(风险比:17.89;95%置信区间:2.13 - 149.79)。在多变量模型中,肾小球上皮增生和间质纤维化是ESKD的重要预测指标。

结论

该研究强调了纤维化与肾功能之间的关联,并确定了肾小球上皮变化和肾功能下降的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/97086e089ed9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/c8ef7ae9079a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/61ed4f6d5fb3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/43b92505eb85/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/041efcead8f7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/d2a4b8f5c288/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/e63cf9165394/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/28196be5775b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/97086e089ed9/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/c8ef7ae9079a/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/61ed4f6d5fb3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/43b92505eb85/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/041efcead8f7/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/d2a4b8f5c288/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/e63cf9165394/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/28196be5775b/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/51bc/8071659/97086e089ed9/gr7.jpg

相似文献

1
The Role of Glomerular Epithelial Injury in Kidney Function Decline in Patients With Diabetic Kidney Disease in the TRIDENT Cohort.肾小球上皮损伤在TRIDENT队列中糖尿病肾病患者肾功能下降中的作用
Kidney Int Rep. 2021 Feb 3;6(4):1066-1080. doi: 10.1016/j.ekir.2021.01.025. eCollection 2021 Apr.
2
Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.血清血红蛋白浓度与糖尿病肾病早期肾功能下降风险:一项基于全国性活检队列研究。
Nephrol Dial Transplant. 2022 Feb 25;37(3):489-497. doi: 10.1093/ndt/gfab185.
3
Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.组织中管状损伤标志物的表达与糖尿病肾病肾功能下降有关。
J Diabetes Complications. 2017 Dec;31(12):1704-1709. doi: 10.1016/j.jdiacomp.2017.08.009. Epub 2017 Aug 24.
4
Renal Histologic Analysis Provides Complementary Information to Kidney Function Measurement for Patients with Early Diabetic or Hypertensive Disease.肾脏组织学分析为早期糖尿病或高血压病患者的肾功能测量提供了补充信息。
J Am Soc Nephrol. 2021 Nov;32(11):2863-2876. doi: 10.1681/ASN.2021010044. Epub 2021 Aug 4.
5
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.非白蛋白尿性慢性肾脏病向终末期肾病进展的风险:CRIC(慢性肾功能不全队列)研究。
Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.
6
Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.镜下血尿是经肾活检证实的糖尿病肾病患者发生终末期肾病的一个危险因素。
BMJ Open Diabetes Res Care. 2020 Nov;8(2). doi: 10.1136/bmjdrc-2020-001863.
7
Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.糖尿病患者肾功能下降的代谢组学标志物:来自慢性肾功能不全队列(CRIC)研究的证据。
Am J Kidney Dis. 2020 Oct;76(4):511-520. doi: 10.1053/j.ajkd.2020.01.019. Epub 2020 May 5.
8
Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease.活检证实的糖尿病肾病中的性别差异。
Front Endocrinol (Lausanne). 2021 Jul 29;12:670674. doi: 10.3389/fendo.2021.670674. eCollection 2021.
9
Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.2 型糖尿病患者尿液酸化功能与糖尿病肾病进展的关系。
J Diabetes Complications. 2019 Nov;33(11):107419. doi: 10.1016/j.jdiacomp.2019.107419. Epub 2019 Aug 19.
10
Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.尿表皮生长因子和单核细胞趋化蛋白-1 与糖尿病肾病患者肾脏受累的关系。
Nephrol Dial Transplant. 2020 Feb 1;35(2):291-297. doi: 10.1093/ndt/gfy314.

引用本文的文献

1
Glycosylation in kidney diseases.肾脏疾病中的糖基化作用。
Precis Clin Med. 2025 Jul 11;8(3):pbaf017. doi: 10.1093/pcmedi/pbaf017. eCollection 2025 Sep.
2
Control of Mitochondrial Quality: A Promising Target for Diabetic Kidney Disease Treatment.线粒体质量控制:糖尿病肾病治疗的一个有前景的靶点。
Kidney Int Rep. 2024 Dec 31;10(4):994-1010. doi: 10.1016/j.ekir.2024.12.029. eCollection 2025 Apr.
3
IgG expressed by renal tubular epithelial cells in epithelial mesenchymal transformation and interstitial fibrosis in diabetic kidney disease.

本文引用的文献

1
Ultrastructural Characterization of Proteinuric Patients Predicts Clinical Outcomes.蛋白尿患者的超微结构特征可预测临床结局。
J Am Soc Nephrol. 2020 Apr;31(4):841-854. doi: 10.1681/ASN.2019080825. Epub 2020 Feb 21.
2
Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study.糖尿病肾病转化研究(TRIDENT)的原理与设计
Kidney Int. 2020 Jan;97(1):10-13. doi: 10.1016/j.kint.2019.09.020.
3
Silhouette width using generalized mean-A flexible method for assessing clustering efficiency.使用广义均值的轮廓宽度——一种评估聚类效率的灵活方法。
糖尿病肾病中肾小管上皮细胞在上皮-间质转化和间质纤维化过程中表达的IgG
Ren Fail. 2025 Dec;47(1):2458764. doi: 10.1080/0886022X.2025.2458764. Epub 2025 Feb 3.
4
Single-cell multi-omic and spatial profiling of human kidneys implicates the fibrotic microenvironment in kidney disease progression.单细胞多组学和空间分析揭示了人类肾脏纤维化微环境在肾脏疾病进展中的作用。
Nat Genet. 2024 Aug;56(8):1712-1724. doi: 10.1038/s41588-024-01802-x. Epub 2024 Jul 24.
5
STAT3-induced upregulation of lncRNA TTN-AS1 aggravates podocyte injury in diabetic nephropathy by promoting oxidative stress.信号转导和转录激活因子3(STAT3)诱导的长链非编码RNA TTN-AS1上调通过促进氧化应激加重糖尿病肾病中的足细胞损伤。
Toxicol Res (Camb). 2024 May 31;13(3):tfae079. doi: 10.1093/toxres/tfae079. eCollection 2024 Jun.
6
Cure Glomerulonephropathy Pathology Classification and Core Scoring Criteria, Reproducibility, and Clinicopathologic Correlations.治愈性肾小球肾病的病理分类及核心评分标准、可重复性和临床病理相关性
Glomerular Dis. 2023 Oct 26;3(1):248-257. doi: 10.1159/000534755. eCollection 2023 Jan-Dec.
7
Single-cell transcriptomics and chromatin accessibility profiling elucidate the kidney-protective mechanism of mineralocorticoid receptor antagonists.单细胞转录组学和染色质可及性分析阐明了盐皮质激素受体拮抗剂的肾脏保护机制。
J Clin Invest. 2024 Jan 2;134(1):e157165. doi: 10.1172/JCI157165.
8
CureGN-Diabetes Study: Rationale, Design, and Methods of a Prospective Observational Study of Glomerular Disease Patients with Diabetes.CureGN-糖尿病研究:糖尿病肾小球疾病患者前瞻性观察性研究的原理、设计与方法
Glomerular Dis. 2023 Jun 26;3(1):155-164. doi: 10.1159/000531679. eCollection 2023 Jan-Dec.
9
Drugs for Diabetes: From Pharmacology to Clinical Application.糖尿病药物:从药理学到临床应用
Pharmaceuticals (Basel). 2023 Sep 24;16(10):1346. doi: 10.3390/ph16101346.
10
Molecular pathways that drive diabetic kidney disease.驱动糖尿病肾病的分子通路。
J Clin Invest. 2023 Feb 15;133(4):e165654. doi: 10.1172/JCI165654.
Ecol Evol. 2019 Nov 19;9(23):13231-13243. doi: 10.1002/ece3.5774. eCollection 2019 Dec.
4
Diabetic kidney diseases revisited: A new perspective for a new era.重新审视糖尿病肾病:新时代的新视角。
Mol Metab. 2019 Dec;30:250-263. doi: 10.1016/j.molmet.2019.10.005. Epub 2019 Oct 17.
5
Epidemiology in diabetes mellitus and cardiovascular disease.糖尿病与心血管疾病的流行病学
Cardiovasc Endocrinol. 2017 Feb 15;6(1):8-16. doi: 10.1097/XCE.0000000000000116. eCollection 2017 Mar.
6
Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen.全基因组关联研究揭示了糖尿病肾病中肾小球基底膜胶原相关的生物学机制。
J Am Soc Nephrol. 2019 Oct;30(10):2000-2016. doi: 10.1681/ASN.2019030218. Epub 2019 Sep 19.
7
mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.mTOR 介导的足细胞肥大调节小鼠和人类的肾小球完整性。
JCI Insight. 2019 Sep 19;4(18):99271. doi: 10.1172/jci.insight.99271.
8
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency.白蛋白尿和肾小球滤过率(GFR)变化作为慢性肾脏病(CKD)早期临床试验的终点:美国国家肾脏基金会与美国食品和药物管理局(FDA)及欧洲药品管理局(EMA)合作举办的科学研讨会
Am J Kidney Dis. 2020 Jan;75(1):84-104. doi: 10.1053/j.ajkd.2019.06.009. Epub 2019 Aug 28.
9
Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning.人工智能利用大数据机器学习预测糖尿病肾病的进展。
Sci Rep. 2019 Aug 14;9(1):11862. doi: 10.1038/s41598-019-48263-5.
10
Changes in Albuminuria But Not GFR are Associated with Early Changes in Kidney Structure in Type 2 Diabetes.尿白蛋白变化而非 GFR 与 2 型糖尿病肾脏结构的早期变化相关。
J Am Soc Nephrol. 2019 Jun;30(6):1049-1059. doi: 10.1681/ASN.2018111166.